Cargando…
Advances in limb salvage treatment of osteosarcoma
Osteosarcoma is the most common primary malignant bone tumor; its standard treatment includes neoadjuvant chemotherapy combined with surgery. Neoadjuvant chemotherapy has significantly improved the 5-year survival and limb salvage rates in osteosarcoma since the 1870s. The survival rate of patients...
Autores principales: | Yang, Yichun, Han, Lei, He, Zewei, Li, Xiaojuan, Yang, Suping, Yang, Jifei, Zhang, Ya, Li, Dongqi, Yang, Yihao, Yang, Zuozhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739147/ https://www.ncbi.nlm.nih.gov/pubmed/29296558 http://dx.doi.org/10.1016/j.jbo.2017.11.005 |
Ejemplares similares
-
A comparative study between limb-salvage and amputation for treating osteosarcoma
por: Li, Xiaojuan, et al.
Publicado: (2016) -
Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma
por: Yang, Zuozhang, et al.
Publicado: (2016) -
Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq
por: Yang, Yihao, et al.
Publicado: (2016) -
Does intensified chemotherapy increase survival outcomes of osteosarcoma patients? A meta-analysis
por: Zhang, Ya, et al.
Publicado: (2018) -
Meta-analysis of differentially expressed genes in osteosarcoma based on gene expression data
por: Yang, Zuozhang, et al.
Publicado: (2014)